These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 1362921

  • 1. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH, Mytilineou C.
    Brain Res; 1992 Dec 18; 599(1):83-97. PubMed ID: 1362921
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture.
    Casper D, Roboz GJ, Blum M.
    J Neurochem; 1994 Jun 18; 62(6):2166-77. PubMed ID: 8189225
    [Abstract] [Full Text] [Related]

  • 3. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D, Unsicker K.
    J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265
    [Abstract] [Full Text] [Related]

  • 4. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
    Bilsland J, Roy S, Xanthoudakis S, Nicholson DW, Han Y, Grimm E, Hefti F, Harper SJ.
    J Neurosci; 2002 Apr 01; 22(7):2637-49. PubMed ID: 11923429
    [Abstract] [Full Text] [Related]

  • 5. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.
    Hou JG, Lin LF, Mytilineou C.
    J Neurochem; 1996 Jan 01; 66(1):74-82. PubMed ID: 8522992
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of the regrowth of MPP+-damaged dopaminergic fibers by the treatment of mesencephalic cultures with basigin.
    Mitsumoto Y, Watanabe A, Miyauchi T, Jimma F, Moriizumi T.
    J Neural Transm (Vienna); 2001 Jan 01; 108(10):1127-34. PubMed ID: 11725815
    [Abstract] [Full Text] [Related]

  • 7. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration.
    Hartikka J, Staufenbiel M, Lübbert H.
    J Neurosci Res; 1992 Jun 01; 32(2):190-201. PubMed ID: 1357186
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.
    Brain Res; 1996 Nov 25; 741(1-2):68-74. PubMed ID: 9001706
    [Abstract] [Full Text] [Related]

  • 10. GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
    Dalia A, Neff NH, Hadjiconstantinou M.
    J Neurosci; 1993 Jul 25; 13(7):3104-11. PubMed ID: 8101212
    [Abstract] [Full Text] [Related]

  • 11. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C, Pardini C, Barachini S, D'Alessandro D, Siciliano G, Murri L, Petrini M, Vaglini F.
    Brain Res; 2011 Jan 07; 1367():94-102. PubMed ID: 20854799
    [Abstract] [Full Text] [Related]

  • 12. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture.
    Beck KD, Knüsel B, Hefti F.
    Neuroscience; 1993 Feb 07; 52(4):855-66. PubMed ID: 8095710
    [Abstract] [Full Text] [Related]

  • 13. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
    Han BS, Hong HS, Choi WS, Markelonis GJ, Oh TH, Oh YJ.
    J Neurosci; 2003 Jun 15; 23(12):5069-78. PubMed ID: 12832530
    [Abstract] [Full Text] [Related]

  • 14. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system.
    Hou JG, Cohen G, Mytilineou C.
    J Neurochem; 1997 Jul 15; 69(1):76-83. PubMed ID: 9202296
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
    Michel PP, Dandapani BK, Knusel B, Sanchez-Ramos J, Hefti F.
    J Neurochem; 1990 Apr 15; 54(4):1102-9. PubMed ID: 1968953
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
    Huang JY, Hong YT, Chuang JI.
    J Neurochem; 2009 Jun 15; 109(5):1400-12. PubMed ID: 19476551
    [Abstract] [Full Text] [Related]

  • 19. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP, Agid Y.
    Brain Res; 1992 Dec 04; 597(2):233-40. PubMed ID: 1361874
    [Abstract] [Full Text] [Related]

  • 20. Basic fibroblast growth factor promotes epidermal growth factor responsiveness and survival of mesencephalic neural precursor cells.
    Santa-Olalla J, Covarrubias L.
    J Neurobiol; 1999 Jul 04; 40(1):14-27. PubMed ID: 10398068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.